Table 1.
Demographic Data
| Variable | Diagnostic Groups | ||
|---|---|---|---|
| Probands (SCZ) (n=211) |
Siblings (n=234) |
Controls (n=355) |
|
| Age (yrs) | 33.7 (9.1) | 35.1 (9.0) | 31.6 (9.5) |
| Sex (M/F) | 168/43 | 68/84 | 139/216 |
| Race # (%) Caucasian | 172 (81.5) | 130 (85.5) | 297 (83.7) |
| Education (yrs) | 14.0 (2.1) | 15.9 (2.4) | 16.8 (2.4) |
| WAIS-FSIQ | 92.2 (11.4) | 106.0 (11.0) | 106.9 (9.7) |
| GAF | 46.4 (15.6) | 85.9 (6.7) | 86.5 (6.3) |
| Probands with and without Enuresis – Neuropsych subset | |||
| Variable | SCZ+Enuresis | SCZ-Enuresis | Group Comparison |
| (n=45) | (n=166) | ||
| Age (yrs) | 33.2 (9.2) | 33.8 (9.0) | t=0.43, p=0.67 |
| Sex (M/F) | 39/6 | 129/37 | χ2=1.75, p=0.19 |
| Race # (%) Caucasian | 38 (84.4) | 134 (80.7) | χ2=0.33, p=0.57 |
| Prodromal Age | 17.1 (6.3) | 19.2 (5.6) | t=2.06, p=0.04* |
| Age Onset Illness | 20.3 (4.8) | 21.6 (5.3) | t=1.39, p=0.17 |
| Education (yrs) | 13.7 (2.1) | 14.1 (2.0) | t=1.21, p=0.23 |
| GAF | 44.8 (13.9) | 46.8 (16.0) | t=0.76, p=0.45 |
| Age Offset Enuresis | 8.3 (3.3) | --- | --- |
| Probands with and without Enuresis – VBM imaging subset | |||
| Variable | SCZ+Enuresis | SCZ+Enuresis | Group Comparison |
| (n=16) | (n=16) | ||
| Age (yrs) | 34.7 (11.2) | 33.1 (9.5) | t=−0.60, p=0.55 |
| Sex (M/F) | 14/2 | 55/11 | Fisher exact, p=0.51 |
| Race # (%) Caucasian | 14 (87.5) | 53 (80.3) | Fisher exact, p=0.40 |
| Prodromal Age | 17.6 (6.8) | 19.7 (5.4) | t=1.31, p=0.20 |
| Age Onset Illness | 20.9 (6.2) | 21.7 (5.3) | t=0.53, p=0.60 |
| Education (yrs) | 13.6 (2.2) | 14.4 (2.2) | t=1.44, p=0.15 |
| GAF | 46.1 (11.8) | 47.7 (15.9) | t=0.39, p=0.70 |
| Age Offset Enuresis | 8.8 (2.6) | --- | |
Mean (SD) unless stated otherwise. SCZ=schizophrenia; WAIS-FSIQ=Wechsler Adult Intelligence Scale-revised, full-scale intelligence quotient; GAF=Global Assessment of Functioning Scale; Prodromal Age=age of onset of prodromal symptoms of schizophrenia
*
p≤0.05.